pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Immunoglobulin A Nephropathy (IgAN); pharmaceutical preparations for the treatment of Alport Syndrome

pharmaceutical preparations; pharmaceutical preparations for the treatment of neurological diseases; pharmaceutical preparations for the treatment of pantothenate kinase-associated neurodegeneration (PKAN)